BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hibi T, Sapisochin G. What is transplant oncology? Surgery. 2019;165:281-285. [PMID: 30471780 DOI: 10.1016/j.surg.2018.10.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Raveh Y, Beduschi T, Hosein PJ, Vianna R, Tekin A, Selvaggi G, Nicolau-Raducu R. Intestinal Autotransplantation and In-Situ Resection of Recurrent Pancreatic Head Intraductal Tubulopapillary Neoplasm with Portal Cavernoma: A Case Report. Transplant Proc 2021:S0041-1345(21)00424-3. [PMID: 34274118 DOI: 10.1016/j.transproceed.2021.05.009] [Reference Citation Analysis]
2 Briceno J. Artificial intelligence and organ transplantation: challenges and expectations. Current Opinion in Organ Transplantation 2020;Publish Ahead of Print. [DOI: 10.1097/mot.0000000000000775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Sapisochin G, Hibi T, Ghobrial M, Man K. The ILTS Consensus Conference on Transplant Oncology: Setting the Stage. Transplantation 2020;104:1119-20. [DOI: 10.1097/tp.0000000000003175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Takahashi N, Yamada Y, Hoshino K, Kawaida M, Mori T, Abe K, Fujimura T, Matsubara K, Hibi T, Shinoda M, Obara H, Isshiki K, Shima H, Shimada H, Kameyama K, Fuchimoto Y, Kitagawa Y, Kuroda T. Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging. Cancers (Basel) 2019;11:E730. [PMID: 31130716 DOI: 10.3390/cancers11050730] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
5 Abreu P, Gorgen A, Oldani G, Hibi T, Sapisochin G. Recent advances in liver transplantation for cancer: The future of transplant oncology. JHEP Rep 2019;1:377-91. [PMID: 32039389 DOI: 10.1016/j.jhepr.2019.07.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
6 Dopazo C, Lladó L, Fondevila C, Macarulla T, Navalpotro B, Ramos E, Fabregat J, Laquente B, Navasa M, Castells L, Bilbao I, C García Valdecasas J, Charco R. Applicability and results of liver transplant combined with neoadjuvant chemo-radiotherapy in the treatment of unresectable hilar cholangiocarcinoma. Cir Esp (Engl Ed) 2021;99:190-9. [PMID: 32682514 DOI: 10.1016/j.ciresp.2020.06.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Abdelrahim M, Esmail A, Abudayyeh A, Murakami N, Saharia A, McMillan R, Victor D, Kodali S, Shetty A, Nolte Fong JV, Moore LW, Heyne K, Gaber AO, Ghobrial RM. Transplant Oncology: An Evolving Field in Cancer Care. Cancers (Basel) 2021;13:4911. [PMID: 34638395 DOI: 10.3390/cancers13194911] [Reference Citation Analysis]
8 Hibi T, Rela M, Eason JD, Line PD, Fung J, Sakamoto S, Selzner N, Man K, Ghobrial RM, Sapisochin G. Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference. Transplantation. 2020;104:1131-1135. [PMID: 32217939 DOI: 10.1097/tp.0000000000003118] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
9 Nadalin S, Genedy L, Königsrainer A. Liver Living Donation for Cancer Patients: Benefits, Risks, Justification. Recent Results Cancer Res 2021;218:135-48. [PMID: 34019167 DOI: 10.1007/978-3-030-63749-1_10] [Reference Citation Analysis]
10 Lang SA, Bednarsch J, Czigany Z, Joechle K, Kroh A, Amygdalos I, Strnad P, Bruns T, Heise D, Ulmer F, Neumann UP. Liver transplantation in malignant disease. World J Clin Oncol 2021; 12(8): 623-645 [PMID: 34513597 DOI: 10.5306/wjco.v12.i8.623] [Reference Citation Analysis]
11 Nadalin S, Settmacher U, Rauchfuß F, Balci D, Königsrainer A, Line PD. RAPID procedure for colorectal cancer liver metastasis. Int J Surg 2020;82S:93-6. [PMID: 32302748 DOI: 10.1016/j.ijsu.2020.03.078] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
12 Tanaka T, Ashat D, Sun S, Laroia S, Karwal M. Performing thermal ablations for hepatomas - is it a worthy skill for hepatologists? Ann Hepatol 2020;19:570-2. [PMID: 32546443 DOI: 10.1016/j.aohep.2020.05.004] [Reference Citation Analysis]
13 Houben P, Schimmack S, Unterrainer C, Döhler B, Mehrabi A, Süsal C. Rare Malignant Indications for Liver Transplantation: A Collaborative Transplant Study Report. Front Surg 2021;8:678392. [PMID: 34926560 DOI: 10.3389/fsurg.2021.678392] [Reference Citation Analysis]
14 Krasnodębski M, Grąt M, Jastrzębski M, Szczęśniak M, Morawski M, Zając K, Patkowski W, Zieniewicz K. Unsatisfactory Long-term Results of Liver Transplant in Patients With Intrahepatic Cholangiocarcinoma. Transplant Proc 2020;52:2463-7. [PMID: 32327261 DOI: 10.1016/j.transproceed.2020.02.095] [Reference Citation Analysis]
15 Ivanics T, Nelson W, Patel MS, Claasen MPAW, Lau L, Gorgen A, Abreu P, Goldenberg A, Erdman L, Sapisochin G. The Toronto Postliver Transplantation Hepatocellular Carcinoma Recurrence Calculator: A Machine Learning Approach. Liver Transpl 2021. [PMID: 34626159 DOI: 10.1002/lt.26332] [Reference Citation Analysis]
16 Kow AWC. Hepatic metastasis from colorectal cancer. J Gastrointest Oncol 2019;10:1274-98. [PMID: 31949948 DOI: 10.21037/jgo.2019.08.06] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
17 Talakić E, Janek E, Mikalauskas S, Schemmer P. Liver Transplantation in Malignancies: A Comprehensive and Systematic Review on Oncological Outcome. Visc Med 2021;37:302-14. [PMID: 34540947 DOI: 10.1159/000517328] [Reference Citation Analysis]
18 Gorgen A, Sapisochin G. Comment on "Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases": What if Those Lesions are Gone? Ann Surg 2021;274:e101. [PMID: 31567348 DOI: 10.1097/SLA.0000000000003606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zawistowski M, Nowaczyk J, Jakubczyk M, Domagała P. Outcomes of ex vivo liver resection and autotransplantation: A systematic review and meta-analysis. Surgery 2020;168:631-42. [PMID: 32727659 DOI: 10.1016/j.surg.2020.05.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
20 Nadalin S, Königsrainer A, Capobianco I, Settmacher U, Rauchfuss F. Auxiliary living donor liver transplantation combined with two-stage hepatectomy for unresectable colorectal liver metastases. Current Opinion in Organ Transplantation 2019;24:651-8. [DOI: 10.1097/mot.0000000000000695] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
21 Giacomoni A, Centonze L, Famularo S, Tripepi M, DeCarlis L. Selection of Hepatocellular Carcinoma Patients for Liver Transplantation: Should the Threshold for Expected Oncological Survival Be Lowered? Transplant Direct 2019;5:e459. [PMID: 31723593 DOI: 10.1097/TXD.0000000000000904] [Reference Citation Analysis]
22 Giorgakis E, Khorsandi SE, Mathur AK, Burdine L, Jassem W, Heaton N. Comparable graft survival is achievable with the usage of donation after circulatory death liver grafts from donors at or above 70 years of age: A long-term UK national analysis. Am J Transplant 2021;21:2200-10. [PMID: 33222386 DOI: 10.1111/ajt.16409] [Reference Citation Analysis]
23 Sapisochin G, Hibi T, Toso C, Man K, Berenguer M, Heimbach J, Greten TF, Pugh TJ, Dawson LA, Mazzaferro V. Transplant Oncology in Primary and Metastatic Liver Tumors: Principles, Evidence, and Opportunities. Ann Surg 2021;273:483-93. [PMID: 33065633 DOI: 10.1097/SLA.0000000000004071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
24 Manzia T, Parente A, Angelico R, Gazia C, Tisone G. The Revolution in Indication for Liver Transplantation: Will Liver Metastatic Disease Overcome the End-Stage Liver Disease in the Next Future? Transplantology 2020;1:111-22. [DOI: 10.3390/transplantology1020011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]